SyMetric’s Integrated Clinical Trial Platform with Interactive Web Response System (IRT/IWRS), Electronic Data Capture (EDC), and Medical Coding on a single database provided an end-to-end solution for one of the global studies. The study was a Randomized, Double-Blind, Placebo-Controlled of different doses of medication in Subjects with a neurological condition. This long-term study was conducted in 3 different locations (the US, Europe, and India) with one CRO and about 100 sites.
Our Unified System provided a centralized platform for the complete study data management for a sample size of more than 800. Stratified Biomarker Analysis based on the group was also implemented by SyMetric CTP for this study.
KEY CHALLENGES ADDRESSED BY OUR PLATFORM IN THIS STUDY
- Releasing the Protocol Amendments to individual Sites in a targeted manner based on their respective IRB Approvals, ensuring system availability to the other Sites with absolutely no downtime.
- Ability to run multiple Study Versions simultaneously on the same Study.
